Fri, March 24, 2017

by: WOPRAI

RWR, FEZ, STO, IYR, DEF, APEI Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

EUO, JO, CRVP, PCRX, FRP, MYY Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

CSII, VGK, BBD, NNBR, PFG, FORR Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

SYT, ENS, HURN, IDT, NRG, DVY Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

EXR, SNY, SNH, SKX, BBG, ZUMZ Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

MPW, GLP, SODA, CMG, HEES, XCO Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

SNX Expected To Be Down After Next Earnings Releases

by: WOPRAI

FHN Expected To Be Down Before Next Earnings Releases

by: WOPRAI

RHT Expected To Be Up After Next Earnings Releases

by: WOPRAI

PGR Expected To Be Up Before Next Earnings Releases

by: WOPRAI

Michael Nemeroff Upgraded (ADBE) to Buy and Increased Target to $150 on, Mar 24th, 2017

by: WOPRAI

Jeff Kvaal Maintained (AAPL) at Strong Buy with Increased Target to $41 on, Mar 24th, 2017

by: WOPRAI

Laura Martin Downgraded (AAPL) to Strong Buy and Increased Target to $41 on, Mar 24th, 2017

by: WOPRAI

Yuriy Vlasov Upgraded (AA) to Strong Buy and Increased Target to $40 on, Mar 24th, 2017

by: WOPRAI

Ivan Feinseth Initiated (AXP) at Hold on, Mar 24th, 2017

by: WOPRAI

Joseph Spak Upgraded (ALV) to Hold on, Mar 24th, 2017

by: WOPRAI

Joseph Pantginis Reiterated (VSTM) at Strong Buy with Increased Target to $78 on, Mar 24th, 2017

by: WOPRAI

Chris Shibutani Initiated (SNDX) at Buy on, Mar 24th, 2017

by: WOPRAI

Liana Moussatos Reiterated (ASND) at Buy with Increased Target to $34 on, Mar 24th, 2017

by: WOPRAI

Randal Konik Upgraded (UAA) to Strong Buy on, Mar 24th, 2017

by: WOPRAI

Brian Brungardt Upgraded (BSM) to Strong Buy on, Mar 24th, 2017

by: WOPRAI

Matthew Niknam Initiated (CCOI) at Strong Buy and Held Target at $48 on, Mar 24th, 2017

by: WOPRAI

Peter Keith Downgraded (SPWH) to Hold on, Mar 24th, 2017

Thu, March 23, 2017

by: WOPRAI

Ladenburg Thalmann Financial Services Inc. (NYSE:LTS), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions

by: WOPRAI

American Vanguard Corporation (NYSE:AVD), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In

by: WOPRAI

Bonso Electronics International, Inc. (NASDAQ:BNSO), Up By $0.47 (20.17%) After BUYINS.NET SqueezeTrigger Report Released on Mo

by: WOPRAI

Caladrius Biosciences Inc. (NASDAQ:CLBS), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

IRTC SqueezeTrigger Price is $29.78. There is $44,797,584 That Short Sellers Still Need To Cover.

by: WOPRAI

Beasley Broadcast Group Inc. (NASDAQ:BBGI), Up By $7.12 (121.51%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, M

by: WOPRAI

Globus Medical Inc. (NYSE:GMED), Up By $7.97 (36.15%) After BUYINS.NET SqueezeTrigger Report Released on Thursday, March 16th 2

by: WOPRAI

Northern Technologies International Corporation (NASDAQ:NTIC), Up By $2.13 (14.02%) After BUYINS.NET SqueezeTrigger Report Rele

by: WOPRAI

Fuwei Films (Holdings) Co. Ltd. (NASDAQ:FFHL), Up By $0.48 (18.68%) After BUYINS.NET SqueezeTrigger Report Released on Wednesda

by: WOPRAI

Direxion Trust Shs Direxion Daily Junior Gold Miners Index Bull 3X ETF (NYSE:JNUG), Down After BUYINS.NET Report Predicted Stoc

by: WOPRAI

Recon Technology Ltd. (NASDAQ:RCON), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In O

by: WOPRAI

Primerica Inc. (NYSE:PRI), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

EMS Find Inc. (PINK:EMSF), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

CYBE, SAH, TEX, NATI, UCTT, GWRE, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

ACNB, YORW, LKFN, FUNC, GABC, SRG, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

CIT, JMP, ACHN, CPLA, GSL Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

HOS, STN, CAE, KND, AXS, KAR Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CYH, WCG, PMT, CYOU, REXX, SCMP Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

EZY, IBKR, XLU, GII, IPE, WBC Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

TGH, PDN, GRI, BWZ, TCRD Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

JKS, SANW, ASPS, CDXS, SFST, VRA Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

Gur Talpaz Upgraded (VRNS) to Strong Buy on, Mar 23rd, 2017

by: WOPRAI

Gary Hovis Maintained (AES) at Hold on, Mar 23rd, 2017

Wed, March 22, 2017

by: WOPRAI

Market Maker Surveillance Report. BAC, DRYS, FXN, GDXJ, JNUG, SUNEQ, Highest Net Sell Volume and Negative Price Friction For W

by: WOPRAI

Market Maker Surveillance Report. SPN, PG, S, CIG, FTR, SGYP, Bearishly Biased Price Friction For Wednesday, March 22nd 2017

Chris Shibutani Initiated (SNDX) at Buy on, Mar 24th, 2017

Chris Shibutani of Cowen & Co., Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Buy on, Mar 24th, 2017.

Chris has made no other calls on SNDX in the last 4 months.



There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with Chris's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Chris

  • Edward White of "FBR Capital" Initiated at Buy and Held Target at $27 on, Thursday, March 16th, 2017
  • Christopher Marai of "Nomura" Initiated at Strong Buy on, Thursday, March 2nd, 2017